|
ZNF256 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.003000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49959999973248E-08 |
| Normal-vs-Stage2 |
2.715600E-02 |
| Normal-vs-Stage3 |
9.861000E-01 |
| Normal-vs-Stage4 |
4.443800E-01 |
| Stage1-vs-Stage2 |
3.802400E-01 |
| Stage1-vs-Stage3 |
1.55117999999232E-05 |
| Stage1-vs-Stage4 |
2.06489999998727E-06 |
| Stage2-vs-Stage3 |
3.327800E-02 |
| Stage2-vs-Stage4 |
1.076330E-02 |
| Stage3-vs-Stage4 |
5.035000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.298730E-03 |
| Normal-vs-AfricanAmerican |
1.624110E-02 |
| Normal-vs-Asian |
4.408000E-01 |
| Caucasian-vs-AfricanAmerican |
2.631800E-01 |
| Caucasian-vs-Asian |
9.782200E-01 |
| AfricanAmerican-vs-Asian |
7.213200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.747600E-02 |
| Normal-vs-Female |
2.23889999995119E-06 |
| Male-vs-Female |
7.937300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.240000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.24739999999235E-05 |
| Normal-vs-Age(61-80Yrs) |
4.156300E-02 |
| Normal-vs-Age(81-100Yrs) |
8.961600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.573200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.473000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.312000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.365700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.435800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.841200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.957300E-04 |
| Normal-vs-Grade 2 |
1.45769996073852E-09 |
| Normal-vs-Grade 3 |
4.528000E-01 |
| Normal-vs-Grade 4 |
1.111580E-01 |
| Grade 1-vs-Grade 2 |
2.486100E-02 |
| Grade 1-vs-Grade 3 |
1.439010E-04 |
| Grade 1-vs-Grade 4 |
2.88569999995492E-06 |
| Grade 2-vs-Grade 3 |
5.48169999947667E-07 |
| Grade 2-vs-Grade 4 |
9.98469995572293E-09 |
| Grade 3-vs-Grade 4 |
4.498200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.68969998998381E-09 |
| Normal-vs-ccB subtype |
2.494400E-01 |
| ccA subtype-vs-ccB subtype |
1.373580E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.715400E-03 |
| Normal-vs-N1 |
2.091400E-01 |
| N0-vs-N1 |
5.560300E-02 |
|
|
